betulinic acid has been researched along with Bone Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, D; Liu, Y; Liu, Z; Luo, L; Wang, L; Wang, M; Wang, Q; Zhang, X | 1 |
| Chung, WY; Kim, HJ; Kim, KR; Lee, CK; Lee, SK; Park, KK; Park, SY | 1 |
2 other study(ies) available for betulinic acid and Bone Cancer
| Article | Year |
|---|---|
Gold nanoshell-based betulinic acid liposomes for synergistic chemo-photothermal therapy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Betulinic Acid; Bone Neoplasms; Combined Modality Therapy; Delayed-Action Preparations; Disease Models, Animal; Drug Therapy; Gold; Humans; Hyperthermia, Induced; Infrared Rays; Liposomes; Mice; Nanoshells; Osteosarcoma; Pentacyclic Triterpenes; Phototherapy; Triterpenes; Tumor Cells, Cultured | 2017 |
Betulinic acid, a bioactive pentacyclic triterpenoid, inhibits skeletal-related events induced by breast cancer bone metastases and treatment.
Topics: Administration, Oral; Animals; Betulinic Acid; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Cathepsin K; Cell Differentiation; Cell Line, Tumor; Cell Survival; Down-Regulation; Estrogens; Female; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred ICR; Osteoclasts; Osteoprotegerin; Parathyroid Hormone-Related Protein; Pentacyclic Triterpenes; RANK Ligand; Triterpenes | 2014 |